Explore our validated organic cosmetics, high-purity biological actives, and advanced processing hardware configured for rapid commercial deployment and international regulatory compliance.
Operating from our centralized, state-of-the-art facility in Miami, Florida, we solve the structural fragilities of traditional outsourced manufacturing through total vertical integration.
Our infrastructure operates under rigorous ISO 22716:2007 protocols, independently audited by SGS. We ensure absolute adherence to U.S. MoCRA (Modernization of Cosmetics Regulation Act) requirements, European Cosmetic Regulation (EC) No 1223/2009, and ASEAN guidelines.
Our formulation laboratory is staffed by veteran cosmetic chemists specialized in clean-chemistry substitution, lipid vesicle encapsulation, and high-performance organic emulsions. We match competitor benchmarks or formulate de novo tailored to your ingredient blacklist.
Unlike conventional contract packers that outsource sensory testing to third-party labs with lengthy turnaround delays, we operate an active, licensed on-site professional testing salon inside our Miami manufacturing campus for instant formula validation.
Our packaging facilities accommodate everything from entry-level runs to multi-million-unit mass retail packaging. We handle luxury heavy-walled glass jars, airless pumps, aluminum tubes, unit-dose sachets, and 128 oz backbar gallons under one single roof.
We formulate to the rigorous ethical benchmarks demanded by conscious consumers. Every formulation complies with Leaping Bunny cruelty-free frameworks, The Good Face Project standards, Credo Clean standards, and Sephora Clean standards.
Formulations compounded within our Miami facility power major product lines sold throughout Target, Ulta Beauty, Whole Foods, Sprouts, CVS, Walmart, Amazon, TikTok Shop, professional salon distributor networks (SalonCentric), medspas, and international retailers.
B2B cosmetic sourcing is transitioning away from superficial marketing claims toward quantifiable biochemical efficacy, strict regulatory traceability, and verifiable supply-chain security.
The enactment of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) in the United States represents the most significant regulatory overhaul of cosmetic safety since 1938. Brands procuring contract manufacturing partners must ensure factories maintain active facility registration, mandatory cosmetic product listings, adverse event reporting systems, and rigorous safety substantiation dossiers.
Procuring from uncertified offshore suppliers exposes brands to severe border detentions and FDA recall liabilities. Partnering with domestic, FDA-registered facilities like ALFA MFG guarantees complete regulatory readiness across all technical files.
Brand owners are moving aggressively toward monomaterial packaging architectures (such as 100% recyclable mono-PP tubes and pumps) and high-percentage Post-Consumer Recycled (PCR) resins (30% to 100% PCR HDPE/PET). This shift eliminates mechanical separation difficulties in municipal recycling systems.
In parallel, corporate buyers are evaluating packaging-to-bulk chemical compatibility to prevent volatile organic leaching, stress-cracking, and premature active oxidation during retail transit and extended warehouse storage.
Geopolitical tensions, trans-oceanic freight inflation, and extended shipping turnaround windows have exposed systemic risks in long-distance offshore OEM sourcing. Leading cosmetic labels are nearshoring compounding and packaging operations back to North American facilities.
Manufacturing in Miami, USA provides brands with agile, compressed 4-to-8-week door-to-door cycle times, eliminating catastrophic inventory lockouts while drastically lowering corporate supply chain carbon footprints.
Tomorrow’s market leaders integrate bio-identical compounds, green chemistry extraction, and advanced cellular carrier vectors to achieve unmatched clinical performance without compromising clean standards.
Natural cosmetic formulation is evolving beyond wild-harvested raw plant extracts toward precision bio-fermentation. By leveraging genetically sequenced non-pathogenic yeasts and microalgae, laboratory bio-fermentation produces active molecules with superior batch-to-batch purity and zero harvest-related seasonal variation.
Harsh broad-spectrum synthetic preservatives and aggressive surfactant configurations can severely disrupt the fragile cutaneous microbiome, compromising epidermal barrier integrity. Forward-thinking formulas utilize multi-functional hurdle preservation systems (such as Caprylyl Glycol, Glyceryl Caprylate, and Levulinic Acid complexes) that inhibit pathogens while preserving commensal microflora.
Modern consumers demand active peptide concentrations backed by verifiable cellular studies. We specialize in stabilizing complex peptide sequences—including copper tripeptides (GHK-Cu), matrix-signaling hexapeptides, and neuro-soothing acetyl peptides—using liposomal delivery and lyophilized cryogenic stabilization to preserve active potency until the moment of application.
Select the structural model aligned with your technical requirements, go-to-market speed, and intellectual property strategy.
| Evaluation Parameter | Ready-to-Brand Private Label | Custom R&D Formulation | Contract Scale Manufacturing |
|---|---|---|---|
| Target Customer | Influencers, New Brands, Medspas, Salons | Brands seeking signature, unique hero SKUs | Established retail brands scaling capacity |
| Formulation Basis | 1,000+ Pre-tested, stable stock formulas | Bespoke synthesis or reverse-engineered benchmark | Client-owned proprietary chemical formula |
| Prototyping Turnaround | Instant dispatch of off-the-shelf samples | 2 to 4 weeks (1 to 3 trial revisions) | Pilot batch technical transfer validation |
| R&D Upfront Fee | $0 (Zero formulation development fees) | $500 – $1,000 (Credited back on 1st run) | Custom pilot scaling fee based on equipment |
| Standard Production Run | 4 to 6 weeks from packaging receipt | 6 to 8 weeks following formula sign-off | 4 to 8 weeks scheduled recurring production |
| Minimum Order Quantities | 2,500 units (container format dependent) | 2,500 units (container format dependent) | 2,500 to 100,000+ units across automated lines |
| Regulatory Dossier Support | Full turnkey COA, SDS, INCI breakdown | Custom safety dossiers, MoCRA listings, EU CPNP | Analytical quality releases, cGMP lot verification |
Detailed technical, regulatory, and financial answers to streamline your factory due diligence and procurement review.
Our minimum order quantities are determined strictly by container physical geometry and automated filling line calibration requirements:
Note for procurement planners: MOQs are calculated on a per-SKU basis to guarantee adequate batch volume inside our sanitary high-shear compounding tanks.
For fully custom formulation development, benchmark reverse-engineering, or novel ingredient substitutions, we charge a modest, transparent R&D fee of USD $500 to $1,000 depending on formula complexity and active load requirements. This development fee includes up to three iterative prototype rounds overseen directly by our senior cosmetic chemists, complete with physical benchmark comparison testing.
Once you approve the target prototype, 100% of this R&D fee is directly credited back as an invoice deduction against your initial commercial production order. We believe in earning your long-term manufacturing business, not profiting from laboratory prototype fees.
Every commercial formulation leaving ALFA MFG undergoes strict, standardized analytical verification following international ICH (International Council for Harmonisation) stability testing guidelines:
Yes. Our in-house analytical laboratory routinely deconstructs market benchmarks to understand exact emulsification systems, rheology modifiers, sensory ester profiles, and active payload ratios. When submitting a benchmark project, simply ship us an unopened retail sample along with your target marketing claims, intended active ingredients, and clean beauty restriction list.
Our chemists analyze the INCI composition, match or exceed its sensory slip, absorption rate, and hydration metrics, and deliver an elevated, clean, non-infringing counterpart within 2 to 4 weeks.
For custom formulation agreements, your business maintains complete commercial exclusivity for your customized product. You own the brand, product identity, customized active profile, and trade dress. If you bring an existing client-owned proprietary formula to our plant under a contract manufacturing agreement, your intellectual property remains 100% yours, strictly protected under signed bilateral non-disclosure agreements (NDAs).
Full formulation master batch records and IP buyout arrangements are transparently codified in our manufacturing service contracts without hidden licensing constraints.
As an active FDA-registered cosmetics facility in Miami, Florida, we handle the complex technical documentation required by modern regulatory frameworks. For domestic U.S. distribution, we provide full facility registration details and structured product data for your mandatory MoCRA cosmetic listings.
For international distribution across the European Union, United Kingdom, Canada, Australia, and Asia, our regulatory compliance division prepares complete Cosmetic Product Safety Reports (CPSR), provides quantitative/qualitative INCI breakdowns, generates 16-point GHS-compliant Safety Data Sheets (SDS), issues Certificates of Free Sale (CFS), and assists in CPNP / UK portal registration dossiers.
We pride ourselves on transparent, reliable manufacturing timelines:
Initiate your custom OEM formulation project today. Connect with our senior cosmetic development specialists, request custom prototype development, or receive our comprehensive formulation catalog and pricing schedule.
Get Catalog